Table 21-13.
Quality of Care by Race/Ethnicity and Sex in the GWTG-Stroke Program
| Quality-of-Care Measure | White | Black | Hispanic | Male | Female |
|---|---|---|---|---|---|
| IV tPA in patients who arrived ≤2 h after symptom onset, treated in ≤3 h* | 76.0 | 75.4 | 77.5 | 76.0 | 76.4 |
| IV tPA in patients who arrived <3.5 h after symptom onset, treated in ≤4.5 h | 41.6 | 43.1 | 47.8 | 43.3 | 41.7 |
| IV tPA door-to-needle time ≤60 min | 29.3 | 27.3 | 32.8 | 31.8 | 27.3 |
| Thrombolytic complications: IV tPA and life-threatening, serious systemic hemorrhage | 12.3 | 16.0 | 15.2 | 13.5 | 12.8 |
| Antithrombotics <48 h after admission* | 96.6 | 95.9 | 95.5 | 96.7 | 96.1 |
| DVT prophylaxis by second hospital day* | 92.2 | 92.4 | 91.1 | 92.5 | 91.9 |
| Antithrombotics at discharge* | 97.9 | 97.2 | 96.9 | 98.0 | 97.4 |
| Anticoagulation for atrial fibrillation at discharge* | 93.6 | 92.9 | 93.4 | 94.0 | 93.1 |
| Therapy at discharge if LDL >100 mg/dL or LDL not measured or on therapy at admission* | 88.0 | 88.6 | 87.9 | 90.2 | 86.3 |
| Counseling for smoking cessation* | 96.8 | 96.7 | 95.6 | 96.7 | 96.6 |
| Lifestyle changes recommended for BMI >25 kg/m2 | 57.5 | 57.9 | 61.3 | 58.2 | 57.4 |
| Composite quality-of-care measure | 93.8 | 93.8 | 93.0 | 94.4 | 93.1 |
GWTG-Stroke indicates Get With The Guidelines–Stroke; IV, intravenous; tPA, tissue-type plasminogen activator; DVT, deep venous thrombosis; LDL, low-density lipoprotein; and BMI, body mass index.
Values are percentages.
*
Indicates the 7 key performance measures targeted in GWTG-Stroke.